The exact influences of thyroid functions on body mass index Background: (BMI) are ill-defined in euthyroid pregnant women with gestational diabetes mellitus (GDM).
Introduction
Abnormal thyroid function and glucose tolerance have been both reported during pregnancy [1] [2] [3] . It was hypothesized that thyroid hormones gradually increase during the first trimester, but decrease gradually over the rest of pregnancy [4] [5] [6] . The steady rise of human chorionic gonadotropin (hCG) hormone during the first trimester was claimed to induce follicular thyroid cells to release of tri-iodothyronine (T3) and thyroxine (T4) 7 , which negatively feedback on thyroid-stimulating hormone (TSH) 8 . During the second and third trimesters, TSH increases while T3 and T4 decrease following hCG withdrawal. Lower levels of free T3 (FT3) and T4 (FT4) over the last two thirds of pregnancy can also be explained by high thyroid hormones transport proteins concentrations induced by placental estrogens 9 . Alternatively, higher levels of diabetogenic hormones, reduced physical activity, decreased energy expenditure, increased carbohydrate consumption, lack of adequate sleep and other stresses during gestation increase insulin requirements of pregnant women 3 . Increased insulin requirement enhances development of gestational diabetes mellitus (GDM) in susceptible pregnant women e.g. obese women 10 , and those with dysfunctional pancreatic β-cells 11 or insulin resistance 12 .
Weight gain is common among subjects with insulin resistance 13 as well as those with hypothyroidism
14
. During pregnancy, the degree of insulin resistance seems to influence levels of thyroid hormones 15 and pattern of change in maternal body mass index (BMI) 16 . In contrast to overt cases of thyroid disorders, the exact influences of T3 and T4 on BMI are ill-defined in euthyroid pregnant women [17] [18] [19] [20] . According to Ashoor et al.,
18
, FT4 decreased while FT3 increased with higher BMI scores. Although paradoxical effects of FT3 and FT4 on maternal weight were also demonstrated in other reports 17, 19 , some studies failed to reproduce these findings 20 . The euthyroid subjects studied by Milionis et al., did not show association between BMI and FT3 or FT4. However, the same study showed significant positive correlations between BMI and total T3 (TT3) as well as between BMI and total T4 (TT4) in females, but not males 20 . The present study aimed to investigate the effects of GDM on the maternal thyroid function and BMI. In addition, correlations between BMI, FT3 and FT4 were assessed to clarify how thyroid hormones affect maternal weight during pregnancy.
Methods
A case-control study was conducted in Saad Abualila Hospital, Khartoum, Sudan from June to August 2015. Pregnant women with singleton pregnancies who attended the hospital antenatal screening for diabetes mellitus were approached to participate in the study. After signing an informed consent, each pregnant woman was asked about her age, obstetric and medical profile. The weight and height were measured and BMI was calculated and expressed as weight (kg)/height (m) 2 . Women were excluded from the study if they were smokers, had history of hypertension and personal history of cardiovascular disease, had previous medical history of diabetes, were taking any medication (apart from iron supplementation), and had prior significant medical illnesses.
Coustan and Carpenter
12 criteria were adopted for the diagnosis of gestational diabetes, by which after a 100-g oral glucose load, two or more of the following plasma values were met or exceeded: fasting 95 mg/dl, 1 h 180 mg/dl, 2 h 155 mg/dl, and 3 h 140 mg/dl. Women with normal values were included as controls.
Venous blood specimens (5 ml) were drawn from the median cubital vein and collected in vacutainer blood-collecting tubes. The tube specimens were allowed to clot and then were centrifuged for 10 min at 3,000×g to separate the serum which was stored at −20°C until analysis for thyroid hormones (TSH, free T3, and free T4) using immunoassay analyzer (AIA 360, Tosoh, Japan), following the manufacturer's instructions. Specific anti-thyroperoxidase (anti-TPO) and anti-thyroglobulin (anti-TG) antibody profiles were analyzed using enzyme-linked immunosorbent assay (ELISA, Euroimmun, Lübeck, Germanykits).
Statistics SPSS for Windows (version 16.0) was used for data analyses. Continue variables were checked for normality and their difference was compared between cases and controls using T-test and Mann-Whitney U, when the data were normally and not normally distributed, respectively. Spearman correlations were performed between the different variables. P < 0.05 was considered statistically significant.
Ethics
The study received ethical clearance from the Research Board at the Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Khartoum, Sudan. Table 1 shows the means (standard deviation, SD) of basic characteristics of the studied GDM patients and control group (34 women in each arm) including the age and gestational age. BMI was significantly higher in GDM patients (26.3 (2.7) Kg/m 2 ) compared with the control group (24.3 (1.8) Kg/m 2 , P = 0.001).
Results
Levels of FT3 and FT4 were significantly decreased in GDM patients (0.632 (0.408-1.074) pg/ml; 0.672 (0.614-0.960) ng/dl respectively) compared with the healthy pregnant women (0.82 (0.510-1.385) pg/ml, P = 0.021; 0.840 (0.767-1.200) ng/dl, P < 0.001 respectively, Table 2 ). In contrast, anti-TPO and anti-TG were significantly higher in GDM patients (11.13 (7.969-13.090) IU/ml; 14.40 (10.91-20.69) IU/ml respectively) compared with the control group (8.90 (6.375-10.48 IU/ml, P = 0.022; 10.50 (8.2-13.95) IU/ml, P = 0.010 respectively), Table 2 , Figure 1 - Figure 5 . BMI correlated negatively with FT3 (r = -0.375, P = 0.002) and FT4 (r = -0.316, P = 0.009) and positively with anti-TPO (r = 0.361, P = 0.002) and anti-TG (r = 0.393, P = 0.010).
There was no significant difference in TSH levels between GDM patients (2.037 (1.053-3.323) mIU//ml) and healthy pregnant women (2.401 (1.888-2.811) mIU//ml, P = 0.283) and no significant correlation with BMI (r = -0.094, P = 0.446), Table 3 . Basic characteristics of participants.
Discussion
In accordance with the present results, previous reports demonstrated an associations between GDM and decreased thyroid hormones, increased anti-thyroid autoantibodies and higher BMI 1, 15, [22] [23] [24] . The associations between FT4, maternal weight, and GDM were recently investigated by Haddow and his group in more than 9000 singleton, euthyroid women in the FaSTER (First and Second Trimester Evaluation of Risk) trial 2 . An earlier report documented an inverse association between maternal weight and FT4 in the second trimester 2 . In a subsequent separate report on the same cohort, FT4 odds ratio for GDM was significant in the second (1.89), but not in the first (1.11) trimester 1 . Comparable findings were shown by Cleary-Goldman et al., when they demonstrated 1.7 odds ratio of hypothyroxinemia in GDM patients during the second trimester 24 . Oguz et al., confirmed decreased FT4 in 50 GDM patients compared with 60 non-GDM pregnant women; however, the mean of FT4 levels remained within the normal reference range in both groups 15 . Cases with isolated maternal hypothyroxinemia constituted 8% and 14% of GDM patients during the second and third trimesters respectively; however, similar cases were absent in the control group 15 . In another study, GDM patients showed lower FT4 compared to healthy pregnant women as well as those with type 1 diabetes mellitus. According to the same study, type 1 diabetic women had higher prevalence of anti-TPO compared with healthy pregnant women 22 .
According to the present findings, BMI correlates negatively with FT3 and FT4, but positively with anti-TPO and anti-TG antibodies. In contrast, our results failed to demonstrate significant correlation between BMI and TSH. Increased odds of hypothyroxinemia and anti-TPO positivity among pregnant women with BMI ≥ 30 kg/m 2 during the first 8 weeks of gestation was reported before 25 . Although several previous studies failed to establish an association between BMI and TSH after 8 weeks of gestation 26-28 , at least one study was able to do so when these two parameters were assessed during early pregnancy 25 . It was hypothesized that the peak of hCG hormone towards the end of the first trimester simulates simultaneous increase of thyroid hormones and reciprocal inhibition of TSH release 7, 8, 18 . Except for a temporal fall of TSH levels by the end of first trimester, both TSH and BMI steadily increase throughout pregnancy 26,27 . This explains why previous studies were able to prove significant positive correlation between BMI and TSH during the early 8 weeks of gestation 25 , but failed to reproduce same results during hCG surge [26] [27] [28] . However, failure of our results as well as other studies 28 to document significant correlation between TSH and BMI during later stages of pregnancy is difficult to explain on the same basis and should motivate researchers in the field to investigate for possible explanation(s).
Although the effects of thyroid hormones on body weight are easy predictable in cases with hypo-and hyperthyroidism, the influences of T3 and T4 on BMI are ill-defined in cases of euthyroidism [26] [27] [28] 19 . In contrast, a Greek study in euthyroid subjects failed to demonstrate the association between BMI and FT3 or FT4. The same study showed significant positive correlations between BMI and TT3 as well as between BMI and TT4 in females, but not males 20 . A possible explanation for different patterns of association between T3, T4 and BMI in previous reports is likely because of failure to adjust for confounders like caloric intake 29, 30 . For example, conversion of T4 to T3 peripheral deiodinases is depressed in cases with caloric deprivation 29 and enhanced with overfeeding 30 . This may explain the reciprocal effects of FT3 and FT4 and consequently the direct association between the FT3/FT4 ratio and BMI in cases with reduced caloric intake 31 . In well-fed states, peripheral deiodinase activity will not be augmented and consequently BMI is expected to correlate positively with thyroid hormones levels 20 . In conditions where FT3 and FT4 are below expected, increased TSH enhances leptin release and consequently BMI 32 . This may explain why FT3 and FT4 may negatively correlate BMI irrespective of caloric intake.
Of note, deiodinase activity and insulin resistance were not assessed in the present study. Direct measures of deiodinase activity (e.g. hepatic deiodinase-1 mRNA) are difficult to evaluate because obtaining the required tissue samples is inconvenient. However, the T3/T4 ratio was proved to correlate well with deiodinase activity and can act as a surrogate for hepatic deiodinase-1 mRNA 31 . Evaluation of insulin resistance using parameters like Homeostasis Model Assessment (HOMA) in future studies will enable more clarification about the potential influence of insulin resistance on the relationship between BMI, FT3 and FT4. Another limitation of this study is that dietary composition and caloric intake were not evaluated among the studied women.
Conclusion
The present results add further evidence for decreased free thyroid hormones, increased anti-thyroid autoantibodies and higher BMI in patients with GDM compared to healthy pregnant women. BMI correlates positively with FT3 and FT4, negatively with anti-TPO and anti-TG antibodies, but failed to demonstrate significant association with TSH. Further studies that also evaluate deiodinase activity, caloric intake and indictors of insulin resistance are desirable for better understanding for the relationship between BMI, FT3 and FT4 in patients with GDM.
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special note on the spacing between words, it seem some spaces are lacking.
Introduction
The physiological changes in thyroid function during pregnancy are well described and accepted by the medical community. Therefore it was weird that the authors referred these as hypothesized and claimed (the first few sentences in the first paragraph). Could the authors reword these sentences? Methods Please add the conversion factor for plasma glucose levels to mmol/l. Please also add the laboratory method used to measure glucose, if available. If not available, please indicate if glucose was measured by a laboratory that participates in an external quality control program. In the Statistics section, please change 'Continue variables' to 'Continuous variables'. Results I presume that the gestational age in Table 1 is the timepoint when women entered the study? If so, please indicate this more clearly. Throughout the manuscript, please spell Kg as kg. Instead of decreased, I would use the word lower when describing differences between GDM cases and controls. Please round all results to two decimals as they are more meaningful clinically (also applies to Table 2 ). Table 1 Please add a space between the mean and SD. Please correct Kg/cm to kg/m Discussion Second line: please correct to 'an association' I think the study by Cleary-Goldman et al. studied the association between thyroid dysfunction and GDM, not the other way around (a subtle but important difference). I would love to see some discussion on the iodine status of the studied population.
Tobago
This article studies the effect of gestational diabetes on maternal thyroid function and BMI. A case control study was done in Sudan and thyroid hormone levels and thyroid autoantibody testing was done.
With the increasing abnormalities in thyroid function such as subclinical disease seen in pregnancy, this study further consolidates existing literature with decreased thyroid hormone levels and increased thyroid autoantibodies in gestational diabetes.
This study also looked at the association between BMI and thyroid parameters. However, the conclusion states that BMI correlates positively with free thyroid hormones but the discussion says a negative correlation was present. Also the conclusion says BMI was negatively associated with thyroid autoantibodies but the discussion says the opposite. I assume this may be a typographical error in the conclusion section. Please address this issue.
Otherwise this study, with its limitations adds interesting data to the preexisting literature on the subject.
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